The COO leveraging the ‘power of we’

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Christiane Bardroff, COO of Rentschler Biopharma SE.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Christiane, covering:

• The importance of "knowing what you're talking about" to build confidence
• Being asked to build and commission an automated €800m bioprocessing plant at Teva
• The draw of a family-owned CDMO business servicing 170 clients worldwide, and what she loves about this ownership model
• The 'power of we' is doing things together as a team for the greater good of the business
• The power of listening to people and empowering teams that led to producing 50% more at the same site
• Why Rentschler Biopharma decided to exit the CGT capabilities and double down on its biologics business

Christiane oversees operations across the company’s sites in Germany and the US. A results-driven executive with a strong foundation in biotechnology and chemical engineering, she brings deep expertise across biomanufacturing, automation, digitalization, and leadership.

Her career includes nearly a decade at Roche, where she implemented the company’s first paperless manufacturing process. At Teva Biotech, she led the development of a €800M large-scale facility and was part of the global management team, earning Teva’s Mission and Values Award in 2021.

Since joining Rentschler in 2022, Christiane has advanced rapidly through senior leadership roles and now leads all operational areas, including manufacturing, quality, engineering, regulatory, and supply chain.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.